The Movement Disorder of Brain-Lung-Thyroid Syndrome Can be Responsive to Methylphenidate

Tremor Other Hyperkinet Mov (N Y). 2017 Oct 26:7:508. doi: 10.7916/D84X5M9Z. eCollection 2017.
No abstract available

Keywords: Chorea; NKX2-1-related disorder; brain-lung-thyroid syndrome; methylphenidate; psychostimulant.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't
  • Video-Audio Media

MeSH terms

  • Athetosis / drug therapy*
  • Athetosis / genetics
  • Athetosis / physiopathology*
  • Central Nervous System Stimulants / therapeutic use*
  • Child
  • Chorea / drug therapy*
  • Chorea / genetics
  • Chorea / physiopathology*
  • Congenital Hypothyroidism / drug therapy*
  • Congenital Hypothyroidism / genetics
  • Congenital Hypothyroidism / physiopathology*
  • Female
  • Humans
  • Methylphenidate / therapeutic use*
  • Respiratory Distress Syndrome, Newborn / drug therapy*
  • Respiratory Distress Syndrome, Newborn / genetics
  • Respiratory Distress Syndrome, Newborn / physiopathology*
  • Thyroid Nuclear Factor 1 / genetics

Substances

  • Central Nervous System Stimulants
  • NKX2-1 protein, human
  • Thyroid Nuclear Factor 1
  • Methylphenidate

Supplementary concepts

  • Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress

Grants and funding